Citing Express Preemption, Court Dismisses Claims Brought Against Pacemaker Manufacturer by Patient’s Estate

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Citing Express Preemption, Court Dismisses Claims Brought Against Pacemaker Manufacturer by Patient’s Estate

Dennis Tosh

April 26, 2023 at 06:29 PM EST

A federal district court has dismissed a complaint brought against a heart pacemaker manufacturer by the estate of a deceased patient, holding that the tort claims brought under California law were expressly preempted by federal law (Estate of Comatov v. Medtronic, Inc., No. 2:23-cv-00165-RGK-E, 2023 U.S. Dist. LEXIS 67199, 2023 WL 2922830 (C.D. Cal. March 16, 2023)). The pat... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Citing Express Preemption, Court Dismisses Claims Brought Against Pacemaker Manufacturer by Patient’s Estate

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT